HowShorted

How shorted is Korro Bio, Inc.?

More shorted than 80% of the 2,877 ranked US companies

9.97%
of shares outstanding reported short · settlement date 31 Jul 2026
vs previous report
−0.15
5 reports (~10 weeks)
+1.69
Aggregate net short position time series for Korro Bio, Inc.
Embed this chart

Paste this snippet to embed the interactive chart. It updates with each FINRA report and keeps the source attribution. Preview

Cite this page

History

Settlement dateShort %Change
31 Jul 20269.97%−0.15
15 Jul 202610.12%−1.70
30 Jun 202611.82%+2.67
15 Jun 20269.15%+0.38
29 May 20268.77%+0.49
15 May 20268.28%+0.53
30 Apr 20267.75%+0.23
15 Apr 20267.52%+0.15
31 Mar 20267.37%+0.31
13 Mar 20267.06%−4.01
27 Feb 202611.07%−0.25
13 Feb 202611.32%−0.73
30 Jan 202612.05%+0.46
15 Jan 202611.59%−0.16
31 Dec 202511.75%−0.98
15 Dec 202512.73%−0.44
28 Nov 202513.17%−2.13
14 Nov 202515.30%+2.93
31 Oct 202512.37%+1.04
15 Oct 202511.33%−3.26
30 Sep 202514.59%−1.15
15 Sep 202515.74%+2.91
29 Aug 202512.83%−0.39
15 Aug 202513.22%+0.55
31 Jul 202512.67%–

Frequently asked questions

How shorted is Korro Bio, Inc. right now?
9.97% of Korro Bio, Inc.'s (KRRO) shares outstanding were reported short for settlement date 31 Jul 2026, per FINRA's consolidated short interest report.
What does this number include?
FINRA member firms must report their short positions in all US equities twice a month; FINRA consolidates them per security. We divide that official share count by the company's shares outstanding from its SEC filings. This is the regulatory figure, not a daily estimate.
Why does it only update twice a month?
US short interest is reported for settlement on the 15th and the last business day of each month, and FINRA publishes the consolidated figures about nine business days later. That cadence is set by regulation; no daily official figure exists.
Which funds are short?
US public short interest is aggregate-only: individual short sellers are not named. Only some EU markets publish named positions.